Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral treatment of allergic rhinitis with Trichuris suis ova
2007-006099-12Phase 2Completed
- Sponsor
- Statens Serum Institut
- Start
- Nov 2007
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of trichuris suis ova in allergic rhinitis (AR) and asthma (2 arms), sponsored by Statens Serum Institut. Primary endpoints: Daily allergic rhinitis symptom score and Number of well days. Started Nov 2007; status: completed.
02
Drugs
trichuris suis ova
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on 2007-006099-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006099-12.